European Companies Search Engine
13 EU fundings (total €7,991,107): Analysis of MRNAs … BdlYear 2008 Financial Transparency System
Text
Crossroads Bank for Enterprises (KBO) 0456.343.923
| 01/02/2008 | EU funding (€1,025.00): APO-SYS |
| 01/07/2008 | EU funding (€1,063,400): Hcpo |
| 01/10/2008 | EU funding (€1,132,629): Moltall |
| 01/09/2008 | EU funding (€1,755,000): Bravissimo |
| 23/12/2008 | EU funding (€10,644.00): Analysis of MRNAs |
| 01/04/2008 | EU funding (€100,000): Adamneuron |
| 01/04/2008 | EU funding (€125,831): Transsiadrug |
| 23/12/2008 | EU funding (€13,681.00): Analysis of MRNAs |
| 01/03/2008 | EU funding (€156,155): Redoxhormone |
| 01/03/2008 | EU funding (€164,887): PHD-Ob-T2D |
| 01/02/2008 | EU funding (€2,980,277): MicroRNAs and Cancer: From Bench to Bedside |
| 01/07/2008 | EU funding (€236,600): Hcpo |
| 01/10/2008 | EU funding (€252,003): Moltall |
This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Vlaams Instituut Voor Biotechnologie - Flanders Institute for Biotechnology VZW, Ghent, Belgium.
The visualizations for "13 EU fundings (total €7,991,107): Analysis of MRNAs …"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
